# Weyerhaeuser Co: overview

WY · NYSE · CIK 106535 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wy.md) · [Financials](/companies/wy/financials.md) · [Filings](/companies/wy/filings.md) · [Insiders](/companies/wy/insiders.md)

Latest reported revenue: [$1.87bn](/filings/0001193125-26-328606.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-328606).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,681](/filings/0001193125-25-260808.md) | [1,708 d](/filings/0001193125-26-051422.md) | [1,763](/filings/0001193125-26-201473.md) | [1,884](/filings/0001193125-26-328606.md) | [1,717](/filings/0001193125-25-260808.md) | [1,541 d](/filings/0001193125-26-051422.md) | [1,727](/filings/0001193125-26-201473.md) | [1,867](/filings/0001193125-26-328606.md) |
| Gross margin | % | [14.9%](/filings/0001193125-25-260808.md) | [17.8% d](/filings/0001193125-26-051422.md) | [19.0%](/filings/0001193125-26-201473.md) | [17.3%](/filings/0001193125-26-328606.md) | [11.9%](/filings/0001193125-25-260808.md) | [10.4% d](/filings/0001193125-26-051422.md) | [18.4%](/filings/0001193125-26-201473.md) | [16.7%](/filings/0001193125-26-328606.md) |
| Operating margin | % | [4.6%](/filings/0001193125-25-260808.md) | [8.3% d](/filings/0001193125-26-051422.md) | [10.2%](/filings/0001193125-26-201473.md) | [9.4%](/filings/0001193125-26-328606.md) | [7.2%](/filings/0001193125-25-260808.md) | [16.3% d](/filings/0001193125-26-051422.md) | [14.3%](/filings/0001193125-26-201473.md) | [11.9%](/filings/0001193125-26-328606.md) |
| Net margin | % | [1.7%](/filings/0001193125-25-260808.md) | [4.7% d](/filings/0001193125-26-051422.md) | [4.7%](/filings/0001193125-26-201473.md) | [4.6%](/filings/0001193125-26-328606.md) | [4.7%](/filings/0001193125-25-260808.md) | [4.8% d](/filings/0001193125-26-051422.md) | [9.0%](/filings/0001193125-26-201473.md) | [8.7%](/filings/0001193125-26-328606.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001193125-25-260808.md) | not reported | [0.11](/filings/0001193125-26-201473.md) | [0.12](/filings/0001193125-26-328606.md) | [0.11](/filings/0001193125-25-260808.md) | not reported | [0.22](/filings/0001193125-26-201473.md) | [0.23](/filings/0001193125-26-328606.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [10.2](/filings/0000950170-24-016434.md) | [10.2](/filings/0000950170-25-021254.md) | [7.7](/filings/0001193125-26-051422.md) | [7.1](/filings/0001193125-26-051422.md) | [6.9](/filings/0001193125-26-051422.md) |
| Gross margin | % | [40.2%](/filings/0000950170-24-016434.md) | [35.5%](/filings/0000950170-25-021254.md) | [21.9%](/filings/0001193125-26-051422.md) | [18.4%](/filings/0001193125-26-051422.md) | [14.8%](/filings/0001193125-26-051422.md) |
| Operating margin | % | [35.7%](/filings/0000950170-24-016434.md) | [30.2%](/filings/0000950170-25-021254.md) | [15.5%](/filings/0001193125-26-051422.md) | [9.6%](/filings/0001193125-26-051422.md) | [10.6%](/filings/0001193125-26-051422.md) |
| Net margin | % | [25.6%](/filings/0000950170-24-016434.md) | [18.5%](/filings/0000950170-25-021254.md) | [10.9%](/filings/0001193125-26-051422.md) | [5.6%](/filings/0001193125-26-051422.md) | [4.7%](/filings/0001193125-26-051422.md) |
| Diluted EPS | $ per share | [3.47](/filings/0000950170-24-016434.md) | [2.53](/filings/0000950170-25-021254.md) | [1.15](/filings/0001193125-26-051422.md) | [0.54](/filings/0001193125-26-051422.md) | [0.45](/filings/0001193125-26-051422.md) |
| Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/wy/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.66bn | 69,464,876 |  | Added +2,100,683 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.45bn | 60,738,699 |  | Reduced −374,583 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $1.23bn | 51,179,282 |  | Added +4,885,818 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $1.23bn | 51,179,282 |  | Added +4,885,818 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.13bn | 47,169,248 |  | Added +228,561 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $1.04bn | 43,574,118 |  | Added +5,437,685 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $821.1m | 34,298,957 |  | Added +1,106,553 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $501.3m | 21,015,027 |  | Added +266,912 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $469.0m | 19,589,359 |  | Added +1,871,488 |
| [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $308.5m | 12,885,150 |  | Reduced −123,482 |

## Recent filings

[All 1,609 filings](/companies/wy/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:09 ET | [8-K](/filings/0001193125-26-437799.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-437799 |
| 2026-09-24 | 12:38 ET | [8-K](/filings/0001193125-26-400727.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-400727 |
| 2026-08-27 | 16:15 ET | [8-K](/filings/0000106535-26-000009.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000106535-26-000009 |
| 2026-07-31 | 16:15 ET | [10-Q](/filings/0001193125-26-328606.md) | Quarterly report, period 2026-06-30 | 0001193125-26-328606 |
| 2026-07-30 | 16:10 ET | [8-K](/filings/0001193125-26-326124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-326124 |
| 2026-06-25 | 16:20 ET | [8-K](/filings/0000106535-26-000007.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000106535-26-000007 |
| 2026-05-28 | 16:30 ET | [8-K](/filings/0000106535-26-000005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000106535-26-000005 |
| 2026-05-20 | 16:17 ET | [8-K](/filings/0000106535-26-000003.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000106535-26-000003 |
| 2026-05-01 | 16:16 ET | [10-Q](/filings/0001193125-26-201473.md) | Quarterly report, period 2026-03-31 | 0001193125-26-201473 |
| 2026-04-30 | 16:10 ET | [8-K](/filings/0001193125-26-197281.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-197281 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-051422.md), filed Feb 13, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/201bdbcd-84b8-4d35-a7c5-a11d02952f1a)

## About the filer

- CIK: 106535
- Tickers: WY
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: WA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:10 ET. No prices; not investment advice.